These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1837647)

  • 1. Adjuvant therapy for non-responders to reduced doses of hepatitis B vaccine during infancy.
    Arya SC
    Vaccine; 1991 Aug; 9(8):604. PubMed ID: 1837647
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
    Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
    Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response to hepatitis B vaccine produced with genetic engineering].
    Ramón Torrell JM; Micheo Salas C; Cerdó Goicouria C; Casas García I; Escribá Jordana JM
    Rev Clin Esp; 1991 Feb; 188(2):68-71. PubMed ID: 2041902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.
    Guan R; Tay HH; Yap I; Smith R; Tan LH
    Trans R Soc Trop Med Hyg; 1990; 84(5):731-2. PubMed ID: 2148992
    [No Abstract]   [Full Text] [Related]  

  • 6. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and efficacy of anti-hepatitis B vaccines in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Maracchione N; Carbone M; Manno C; Proscia F
    Nephron; 1992; 61(3):324-5. PubMed ID: 1386904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccine: extending immunogenicity.
    Horton RC
    Br J Hosp Med; 1990 Jun; 43(6):409. PubMed ID: 2364233
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immune response to recombinant anti-hepatitis-B vaccine in a group at risk].
    León A; García Marcos JA; Nash R; Asensio A; Sanz T; Mateos Lindemann M
    Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):660-1. PubMed ID: 2151508
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine.
    Just M; Berger R; Scheiermann N
    Vaccine; 1988 Oct; 6(5):401-2. PubMed ID: 2973694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice.
    Cooper PD; Turner R; McGovern J
    Immunol Lett; 1991 Feb; 27(2):131-4. PubMed ID: 1827427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules.
    Scheiermann N; Gesemann M; Maurer C; Just M; Berger R
    Vaccine; 1990 Mar; 8 Suppl():S44-6; discussion S60-2. PubMed ID: 2139282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal hepatitis B virus vaccination for low- or non-responded health-care workers.
    Yasumura S; Shimizu Y; Yasuyama T; Hiroki O; Okada K; Tsukishiro T; Tsuchida T; Higuchi K; Watanabe A
    Acta Med Okayama; 1991 Dec; 45(6):457-9. PubMed ID: 1838229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patients: a two-year follow-up.
    Docci D; Cipolloni PA; Mengozzi S; Baldrati L; Capponcini C; Feletti C
    Nephron; 1992; 61(3):352-3. PubMed ID: 1386909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy.
    Giammanco G; Li Volti S; Mauro L; Bilancia GG; Salemi I; Barone P; Musumeci S
    Vaccine; 1991 Oct; 9(10):747-50. PubMed ID: 1836919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(33):569-72. PubMed ID: 1830921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.